---
title: "Limits of Postpartum Psychiatry Revealed by the Lindsay Clancy Case"
id: "stat-news-1-opinion-the-lindsay-clancy-case-shows-the-limits-of-postpartum-psychiatry"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-1-opinion-the-lindsay-clancy-case-shows-the-limits-of-postpartum-psychiatry"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/12/lindsay-clancy-postpartum-psychosis-diagnosis-treatment-limits/?utm_campaign=rss"
published_at: "2026-08-12T14:51:09.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Limits of Postpartum Psychiatry Revealed by the Lindsay Clancy Case
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-1-opinion-the-lindsay-clancy-case-shows-the-limits-of-postpartum-psychiatry
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/12/lindsay-clancy-postpartum-psychosis-diagnosis-treatment-limits/?utm_campaign=rss)
- **Published At:** 2026-08-12T14:51:09.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Lindsay Clancy case has prompted national debate and highlights shortcomings in current understanding and treatment of **postpartum psychiatric illness**, including diagnostic uncertainty and constrained therapeutic options. - Postpartum depression affects about **1 in 7 to 1 in 8 women** after childbirth; diagnosis mainly depends on patient report and clinical interview rather than objective biologic tests. - **Postpartum psychosis** is rare and can have a waxing-and-waning course, complicating timely recognition and intervention. - Screening questionnaires are useful but imperfect; symptoms may be hidden or atypical, delaying identification and care. - Standard treatments such as **SSRIs** are widely used but take weeks to act, are not universally effective, and may be inappropriate for some diagnostic presentations. - Newer rapid-acting treatments show promise but highlight access and equity problems, including high cost and limited availability. - Overlap among postpartum depression, psychosis, anxiety disorders, and bipolar-spectrum illness makes differential diagnosis difficult; clinicians often lack objective tests common in other medical fields. - The authors call for greater investment in predictive **biomarkers** (eg, epigenetic signatures) that could identify at-risk women during pregnancy, forecast treatment response, and signal need for intensified monitoring. - Even with compassionate care, current postpartum psychiatry lacks the precision needed to prevent all tragedies; improved diagnostic tools and targeted therapies could reduce harm. - The commentary is authored by reproductive psychiatrists and neuroscientists who did not treat Clancy; one author discloses a pending patent application related to a biomarker approach for psychiatry with no personal financial benefit reported.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/12/lindsay-clancy-postpartum-psychosis-diagnosis-treatment-limits/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/12/lindsay-clancy-postpartum-psychosis-diagnosis-treatment-limits/?utm_campaign=rss) [chronic disease](https://www.statnews.com/topic/chronic-disease/) [Cancer](https://www.statnews.com/topic/cancer/) [aging](https://www.statnews.com/topic/aging/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) Opinion[First Opinion](https://www.statnews.com/category/first-opinion/) # The Lindsay Clancy case shows the limits of postpartum psychiatry ## Treatment options are limited, diagnosis is complicated, and the science is unfinished * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/12/lindsay-clancy-postpartum-psychosis-diagnosis-treatment-limits/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/08/AP26223692576154-645x645.jpg) Lindsay Clancy in court. Her case has sparked national conversation about postpartum mental health.Jonathan Wiggs/The Boston Globe via AP, Pool By Jamie Maguire, Lauren M. Osborne, and Jennifer Payne Aug. 12, 2026 Maguire is a professor of neuroscience at Tufts University School of Medicine. Osborne is an associate professor of obstetrics and gynecology and psychiatry and a reproductive psychiatrist at NewYork-Presbyterian and Weill Cornell Medicine. Payne is vice chair of research and a professor at the University of Virginia in the Department of Psychiatry and Neurobehavioral Sciences, as well as the director of the Reproductive Psychiatry Research Program, UVA Health. The [Lindsay Clancy case](https://www.bostonglobe.com/2026/08/11/metro/lindsay-clancy-day-11-court-testimony-jollotta/) has become one of the most painful and polarizing stories in recent American memory. At its center are the unimaginable deaths of three young children and a mother whose mental state has become the subject of intense legal, medical, and public scrutiny. The criminal justice system will determine legal responsibility, but regardless of the trial’s outcome, the case exposes a larger and uncomfortable truth: Our understanding and treatment of postpartum psychiatric illnesses remain profoundly inadequate. For many observers, the debate has become a binary one. Either Clancy was suffering from a severe postpartum psychiatric disorder, or she was not. Either she is guilty of murder, or she is not. Either the system failed her, or it did not. And, despite numerous attempts to seek medical care, she was either inappropriately medicated or not. Advertisement The truth is probably not that simple. Even if the system worked perfectly — and it rarely does, especially with complicated cases — there are limitations in what we can currently offer women experiencing postpartum mental illness. This case exposes the gaps in current diagnostic and therapeutic systems and the challenges of identifying which women are at greatest risk, predicting who will respond to treatment, and recognizing early when a patient is deteriorating despite receiving care. We are reproductive psychiatrists and neuroscientists who have not treated Clancy, but this case is a painful reflection of what we already knew: We need better options for patients suffering from postpartum mental health issues. Postpartum depression affects [roughly 1 in 7 to 1 in 8 women](https://pubmed.ncbi.nlm.nih.gov/31298606/) after childbirth, making it among the most common complications of pregnancy. Yet diagnosis remains largely dependent on self-reported symptoms and clinical interviews rather than objective biological tests. Clinicians often rely on screening questionnaires, which are valuable but imperfect. A woman may minimize or hide symptoms out of shame, fear of losing her child, or concern that she will be judged as a bad mother. Others may present with atypical symptoms that do not fit neatly into diagnostic categories. In contrast to postpartum depression, postpartum psychosis is extremely rare and has a “waxing and waning” course, meaning that a woman can appear to be OK at one moment and extremely ill at another point in time. This makes postpartum psychosis challenging even for experienced clinicians to diagnose. By the time severe illness becomes obvious, opportunities for prevention may already have been lost and tragedy may have already struck. Advertisement Treatment options, while helpful for many patients, have significant limitations. Standard antidepressants such as selective serotonin reuptake inhibitors (SSRIs) are frequently used because they are familiar, widely available, and well tolerated. However, they generally require weeks to become fully effective, do not work for everyone, and may even be contraindicated depending on the exact diagnosis. Related Story ![](https://www.statnews.com/wp-content/uploads/2023/06/DSC01584-1-768x432.jpg) ### [‘I felt like I was dying’: How women with postpartum depression fall through the cracks of U.S. health care](https://www.statnews.com/2023/06/26/i-felt-like-i-was-dying-how-women-with-postpartum-depression-fall-through-the-cracks-of-u-s-health-care/) Recent advances offer some hope. Newer medications have demonstrated [more rapid symptom improvement](https://www.statnews.com/2023/08/04/fda-approves-sage-therapeutics-rapid-acting-medication-for-postpartum-depression-but-not-major-depression/) than traditional antidepressants but still do not work for everyone. In addition, these newer therapies also underscore additional limitations of our current system, which include inequities in access due in part to the high cost. Unfortunately, determining which medication will help a specific patient often still involves a frustrating process of trial and error. The Clancy case also highlights another challenge: Postpartum depression, postpartum psychosis, anxiety disorders, and bipolar-spectrum illness can present with overlapping symptoms. Distinguishing among them is often extraordinarily difficult, even for experts. In many areas of medicine, physicians can order laboratory tests, imaging studies, or genetic analyses to help guide diagnosis. In postpartum psychiatry, clinicians usually must make critical decisions without comparable objective tools. This is why the search for predictive biomarkers deserves far greater attention and investment. Imagine if obstetricians could identify during pregnancy which women were at high risk for severe postpartum depression. Imagine if a blood test could predict who would respond to a specific therapy, who required more intensive monitoring, or who was at risk of progressing toward a psychiatric emergency. Such advances would not eliminate tragedy completely, but they could dramatically improve outcomes. Promising research already exists. Investigators have identified epigenetic signatures and other biological markers that may predict postpartum depression risk before symptoms emerge. Advertisement The broader lesson from the Lindsay Clancy case is not that medicine failed because it lacked compassion. Rather, it may have failed because it lacked precision. _Jamie Maguire, Ph.D., is a professor of neuroscience at Tufts University School of Medicine._ _Lauren M. Osborne, M.D., is an associate professor of obstetrics and gynecology and psychiatry and a reproductive psychiatrist at NewYork-Presbyterian and Weill Cornell Medicine._ _Jennifer Payne, M.D., is vice chair of research and a professor at the University of Virginia in the Department of Psychiatry and Neurobehavioral Sciences, as well as the director of the Reproductive Psychiatry Research Program, UVA Health. Disclosure: Maguire is a named inventor on a pending U.S. patent application related to a biomarker approach for psychiatry. The application is pending and no patent has been granted. She receives no personal financial benefit from the patent_. * * * ###### Letter to the editor Have an opinion on this essay? [Submit a letter to the editor](https://www.statnews.com/submit-a-letter-to-the-editor/?subject=The%20Lindsay%20Clancy%20case%20shows%20the%20limits%20of%20postpartum%20psychiatry). [legal](https://www.statnews.com/topic/legal/), [Mental Health](https://www.statnews.com/topic/mental-health/), [reproductive health](https://www.statnews.com/topic/reproductive-health/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. Jamie Maguire 2. Lauren M. Osborne 3. Jennifer Payne ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/First-Opinion-Logo-Black-640x319.png) ### Newsletter The smartest thinkers in life sciences on what's happening — and what's to come Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/STAT_AIBillingSystem_F1_3000-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health care](https://www.statnews.com/2026/08/12/inside-commure-athelas-mad-dash-automate-health-care/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_378516400-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say](https://www.statnews.com/2026/08/12/neurocrine-biosciences-vykat-prader-willi/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AP19249640417394-80x80.jpg) [How we know that splitting up the MMR vaccine could be dangerous](https://www.statnews.com/2026/08/11/how-we-know-splitting-up-mmr-vaccine-could-be-dangerous/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2202122601-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Trump is counting on the health care industry to remake vaccines. It’s pushing back instead](https://www.statnews.com/2026/08/11/health-care-pharma-industry-pushes-back-trump-vaccine-policy-changes/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1260243913-80x80.jpeg) [MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them](https://www.statnews.com/2026/08/05/prostate-cancer-screening-biopsy-vs-mri-debate/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2025/08/VCFirms2025_LeftRailUnit-328x426.png) 2025 Edition: Ranking Biotech’s Top Venture Capital Firms ](https://reports.statnews.com/products/biotech-top-venture-capital-firms-2025) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1666307366-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety](https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2245399768-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [NIH plans to block international researchers on visas from accessing key funding avenue ](https://www.statnews.com/2026/08/07/nih-k99-pathways-independence-awards-scientists-on-visas-barred/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/C0508954-Tau_protein_clusters_TEM-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Study reveals new role for tau, a top target for Alzheimer’s drug development](https://www.statnews.com/2026/08/06/research-finds-how-tau-targets-cells-structure-alzheimers-drug-development/) 4. ![](https://www.statnews.com/wp-content/uploads/2023/04/AdobeStock_521699065_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatment](https://www.statnews.com/2026/08/10/itm-radiopharma-fda-rejection/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/07/AdobeStock_2111261602_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Eli Lilly to allow more patients to apply for special access to unapproved obesity drug](https://www.statnews.com/2026/08/03/eli-lilly-retatrutide-mystery-patient-doctors-seek-same-access-their-patients/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion August 12, 2026 ### [ Climate change is making people with chronic illness even sicker ](https://www.statnews.com/2026/08/12/climate-change-chronic-disease-heat-smoke-arthritis-lupus-pots/) By Lorraine Boissoneault ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion August 11, 2026 ### [ Trump says his executive
## Related Clinical Research

- [Definium Therapeutics reports Phase 3 LSD pill DT120 reduced anxiety in generalized anxiety disord](https://medichelpline.com/clinical-feed/stat-news-1-stat-definium-therapeutics-says-its-lsd-therapy-eased-anxiety-in-late-stage.md)
- [Handshake in Medicine: Why Clinicians Should Reconsider Shaking Hands](https://medichelpline.com/clinical-feed/stat-news-4-opinion-medicine-stopped-shaking-hands-we-should-start-again.md)
- [Reduced added sugar in the first 1,000 days tied to lower Alzheimer’s and dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-cutting-added-sugar-before-age-2-linked-to-lower-dementia-depression-risk-in.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [ENDO 2026: Progress and Resilience in Endocrinology and Obesity Care](https://medichelpline.com/clinical-feed/endocrine-news-0-endo-2026-progress-and-resilience.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.